These findings revealed that TRIM72 plays a critical role in ALI, and exogenous-recombinant TRIM72 protein may be a shelf stable therapeutic agent with the potential to restore lung function and lessen the impact of ALI. This evidence concerns the gene TRIM72 and acute respiratory distress syndrome.